NTLA icon

Intellia Therapeutics

291 hedge funds and large institutions have $2.68B invested in Intellia Therapeutics in 2023 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 122 increasing their positions, 77 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership:

more capital invested

Capital invested by funds: $ → $

3% more funds holding

Funds holding: 283291 (+8)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

30% less call options, than puts

Call options by funds: $21.1M | Put options by funds: $30.2M

Holders
291
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$21.1M
Puts
$30.2M
Net Calls
Net Calls Change

Top Buyers

1 +$61M
2 +$44.6M
3 +$30.6M
4
Marshall Wace
Marshall Wace
United Kingdom
+$27.2M
5
BlackRock
BlackRock
New York
+$26.8M

Top Sellers

1 -$21.7M
2 -$9.34M
3 -$8.73M
4
Millennium Management
Millennium Management
New York
-$7.37M
5
Norges Bank
Norges Bank
Norway
-$6.59M
Name Holding Trade Value Shares
Change
Change in
Stake
126
$724K
127
$717K
128
$713K
129
$704K
130
$702K
131
$695K
132
$695K
133
$688K
134
$686K
135
$666K
136
$658K
137
$640K
138
$634K
139
$633K
140
$624K
141
$618K
142
$610K
143
$606K
144
$591K
145
$587K
146
$581K
147
$580K
148
$579K
149
$555K
150
$519K